Third industry stakeholder platform on research and development support
EventCorporate
Spanish is available via eTranslation, the European Commission's machine translation service.
Translate to Spanish | Important information about machine translation
Date
- Viernes, 18 Mayo 2018, Todo el día
Lugar
- European Medicines Agency, Amsterdam, the Netherlands
This third meeting between regulators and representatives of industry stakeholder organisations addresses all areas of product-development support, including scientific advice, specifics for paediatric and orphan medicines and support for innovation. The meeting focuses on the implementation of the orphan notice, 'histology-independent indications' in the context of orphan designations, the upcoming rollout of a new tool for orphan designation applications, digital technology proposals in medicine development programmes, co-development with companion diagnostics and cross-decision maker collaboration in the space of horizon scanning activities. It also provides an opportunity for updates on post-authorisation evidence generation activities, paediatric medicines and the PRIME scheme.